Improved intratumoral penetration of radiolabeled streptavidin in intrapentoneal tumors pretargeted with biotinylated antibody

Journal of Nuclear Medicine

Volumn 39, Issue 1, 1998, Pages 30-33

  Zhang, Meili ^b   Yao, Zhengsheng ^b   Saga, Tsuneo ^b   Sakahara, Harumi ^a   Nakamoto, Yuji ^b   Sato, Noriko ^b   Nakada, Hiroshi ^b   Yamashina, Ikuo ^b   Konishi, Junji ^b  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

Biotinylated antibody; Intraperitoneal tumor; Intratumoral penetration; Radiolabeled streptavidin

Indexed keywords

BIOTIN; IODINE 125; MONOCLONAL ANTIBODY MLS 128; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; DRUG PENETRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRATUMORAL DRUG ADMINISTRATION; ISOTOPE LABELING; MOLECULAR SIZE; MOUSE; NONHUMAN; PERITONEUM TUMOR; PRIORITY JOURNAL; RADIOIODINATION; TISSUE DISTRIBUTION;

ANIMALS; AUTORADIOGRAPHY; BIOTIN; COLONIC NEOPLASMS; HUMANS; INDICATORS AND REAGENTS; IODINE RADIOISOTOPES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; PERITONEAL NEOPLASMS; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY; STREPTAVIDIN; TISSUE DISTRIBUTION;

EID: 0031931681     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Saga T, Neumann RD, Heya T, et al. Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier. Proc Natl Acad Sci USA 1995;92:8999-9003.
2. 131I-9.2.27 monoclonal antibody in human malignant melanoma. Cancer Res 1989;49:2783-2789.
3. Juweid M, Neumann R, Paik C, et al. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res 1992;52:5144-5153.
4. Blumenthal RD, Fand I, Sharkey RM, Boerman OC, Kashi R, Goldenberg DM. The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: an autoradiographic study. Cancer Immunol Immunother 1991;33:351-358.
5. Ito T, Griffin TW, Collins JA, Brill AB. Intratumoral and whole-body distributions of C110 anti-carcinoembryonic antigen radioimmunotoxin after intraperitoneal and intravenous injection: a quantitative autoradiographic study. Cancer Res 1992;52:1961-1967.
6. Ong GL, Mattes MJ. Penetration and binding of antibodies in experimental human solid tumors grown in mice. Cancer Res 1989;49:4264-4273.
7. Jones PL, Gallagher BM, Sands H. Autoradiographic analysis of monoclonal antibody distribution in human colon and breast tumor xenografts. Cancer Immunol Immunother 1986;22:139-143.
8. Shockley TR, Lin K, Nagy JA, et al. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res 1992;52:367-376.
9. Carlsson J, Daniel-Szolgay E, Frykholm G, Glimelius B, Hedin A, Larsson B. Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids. Cancer Immunol Immunother 1989;30:269-276.
10. Weinstein JN, Eger RR, Covell DG, et al. The pharmacology of monoclonal antibodies. Ann NY Acad Sci 1987;507:199-210.
11. Fujimori K, Covell DG, Fletcher JE, Weinstein JN. A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. J Nucl Med 1990;31: 1191-1198.
12. Weinstein JN, van Osdol W. Early intervention in cancer using monoclonal antibodies and other biological ligands: micropharmacology and the "binding site barrier." Cancer Res 1992;52(suppl):2747S-2751S.
13. Goodwin DA. Tumor pretargeting: almost the bottom line. J Nucl Med 1995;36:876-879.
14. Hnatowich DJ, Virzi F, Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 1987;28:1294-1302.
15. Goodwin DA, Meares CF, Watanabe N, et al. Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy. Cancer Res 1994;54:5937-5946.
16. Paganelli G, Belloni C, Magnani P, et al. Two-step tumour targeting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin. Eur J Nucl Med 1992;19:322-329.
17. Zhang M, Sakahara H, Yao Z, et al. Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody. Nucl Med Biol 1997;24:61-64.
18. Saga T, Weinstein JN, Jeong JM, et al. Two-step targeting of experimental lung metastases with biotinylated antibody and radiolabeled streptavidin. Cancer Res 1994;54:2160-2165.
19. Sung C, van Osdol WW, Saga T, et al. Streptavidin distribution in metastatic tumors pretargeted with a biotinylated monoclonal antibody: theoretical and experimental pharmacokinetics. Cancer Res 1994;54:2166-2175.
20. Griffin TW, Collins J, Bokhari F, et al. Intraperitoneal immunoconjugates. Cancer Res 1990;50(suppl):1031S-1038S.
21. Nakada H, Numata Y, Inoue M, et al. Elucidation of an essential structure recognized by an anti-GalNAc α-Ser(Thr) monoclonal antibody (MLS128). J Biol Chem 1991; 266:12402-12405.
22. Nakada H, Inoue M, Numata Y, et al. Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS128). Proc Natl Acad Sci USA 1993;90:2495-2499.
23. Yao Z, Sakahara H, Zhang M, et al. Radioimmunoimaging of colon cancer xenografts with anti-Tn monoclonal antibody. Nucl Med Biol 1995;22:199-203.
24. Green NM. Avidin. Adv Protein Chem 1975;29:85-133.
25. Sakahara H, Endo K, Koizumi M, et al. Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies. J Nucl Med 1988;29:235-240.
26. Saga T, Endo K, Nakashima T, et al. Construction of an immunoradiomctric assay for ovarian cancer associated antigen CA 125 recognizing different antigenic determinant. Acta Obstet Gynecol Scand 1990;69:175-181.
27. Yao Z, Zhang M, Kobayashi H, et al. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase. J Nucl Med 1995;36:837-841.
28. Rowlinson G, Snook D, Busza A, Epenetos AA. Antibody-guided localization of intraperitoneal tumors following intraperitoneal or intravenous antibody administration. Cancer Res 1987;47:6528-6531.
29. Fujimori K, Covell DG, Fletcher JE, Weinstein JN. Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab′)2, and Fab in tumors. Cancer Res 1989;49:5656-5663.
30. Yokota T, Milenic DE, Whitlow M, Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 1992;52:3402-3408.